1. Home
  2. CTAS vs BMY Comparison

CTAS vs BMY Comparison

Compare CTAS & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cintas Corporation

CTAS

Cintas Corporation

HOLD

Current Price

$206.48

Market Cap

78.1B

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$60.74

Market Cap

114.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTAS
BMY
Founded
1968
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.1B
114.0B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CTAS
BMY
Price
$206.48
$60.74
Analyst Decision
Buy
Buy
Analyst Count
12
15
Target Price
$222.75
$61.93
AVG Volume (30 Days)
1.5M
11.6M
Earning Date
03-19-2026
01-01-0001
Dividend Yield
0.90%
4.04%
EPS Growth
N/A
N/A
EPS
2.41
N/A
Revenue
$6,892,303,000.00
N/A
Revenue This Year
$10.48
N/A
Revenue Next Year
$7.43
N/A
P/E Ratio
$83.20
$17.26
Revenue Growth
N/A
N/A
52 Week Low
$180.39
$42.52
52 Week High
$229.24
$63.33

Technical Indicators

Market Signals
Indicator
CTAS
BMY
Relative Strength Index (RSI) 67.39 54.79
Support Level $182.87 $59.23
Resistance Level $226.65 $62.05
Average True Range (ATR) 4.19 1.20
MACD 0.45 -0.17
Stochastic Oscillator 79.02 39.25

Price Performance

Historical Comparison
CTAS
BMY

About CTAS Cintas Corporation

Cintas has roots tracing back to 1929, during which the Farmer family cleaned and re-sold dirty rags to manufacturing plants in Ohio. The firm has grown its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. In the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid, fire, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: